The Defense Health Agency awarded a $1,694,245 Project Grant to New York University (NYU) School of Medicine, a private non-profit research institution and medical school, to develop innovative therapeutics against pressure ulcer-associated bacteria. The 4-year grant, which runs from August 2023 to August 2027, is funded under the Military Medical Research and Development program (CFDA 12.420). Through this award, NYU School of Medicine will conduct research to identify and advance new...
The Department of the Army Medical Command awarded New York University School of Medicine a $749,343 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, effective August 1, 2025 through July 31, 2027, supports research on a P15-1 peptide treatment for cartilage injuries and post-traumatic osteoarthritis. As a leading academic medical center, New York University School of Medicine will leverage its expertise in biomedical research,...
The federal Project Grant award of $2,013,978.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research by New York University School of Medicine to study the metabolic effects and disease mitigation of particulate matter exposure and the role of the RAGE (Receptor for Advanced Glycation End products) signaling pathway. The award, which runs from July 1, 2025 to June 30, 2028, aims to transform healthcare for military...
This federal Project Grant award of $2,278,276.00 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) will fund research by New York University (NYU) to optimize psychological health and prevent clinical problems. The three-year project will test the effectiveness of an evidence-based toolkit for integrated operational support. NYU has extensive experience conducting federal grant-funded research across a range of domains,...
The U.S. Department of the Army Medical Command awarded a $254,153 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to New York University (NYU) School of Medicine on March 1, 2025. The grant supports advanced biomedical research focused on transforming healthcare for military service members and the broader public, with a specific focus on microplastics and prostate cancer. The research, which is scheduled for completion by February 28, 2027, aims to...
The Department of the Army Medical Command awarded New York University School of Medicine a $1,186,500 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2024 to understand the transition from nevi to melanoma occurring within the skin epidermis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...
The New York University will receive $936,199 under a Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Under this three-year award beginning September 2022, New York University researchers will investigate receptors in endosomes that mediate chronic pain associated with trauma,...
This federal Project Grant award, totaling $3,602,532.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports the development of a sustained-release drug delivery device to manage biofilm implant-related infections in the spine and lateral femur. The primary awardee is the University of Utah, which has a strong track record of executing complex medical research projects for federal agencies. The...
This $1,199,997.00 Project Grant award from the Defense Health Agency, under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), is funding research to prevent trauma-related infections during prolonged care. The grant was awarded on Sep 30, 2023 to The Trustees Of The University Of Pennsylvania - doing business as Clinical Practices Of The University Of Pennsylvania, a private university and non-profit research institution. The research aims to develop...
New York University School of Medicine was awarded a $762,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project titled "BEYOND VEXAS AND UBA1: IDENTIFICATION OF NOVEL DRIVERS OF MDS AUTOIMMUNE SYNDROMES" from June 15, 2023 through June 14, 2026. The grant supports research to identify novel drivers of myelodysplastic syndromes, blood disorders that can progress...